Ryman Healthcare Statistics

Total Valuation

Ryman Healthcare has a market cap or net worth of NZD 3.43 billion. The enterprise value is 5.95 billion.

Market Cap	3.43B
Enterprise Value	5.95B

Important Dates

The next estimated earnings date is Wednesday, November 27, 2024.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Ryman Healthcare has 685.15 million shares outstanding. The number of shares has increased by 33.18% in one year.

Current Share Class	n/a
Shares Outstanding	685.15M
Shares Change (YoY)	+33.18%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.91%
Owned by Institutions (%)	55.77%
Float	651.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	13.68
PS Ratio	5.00
PB Ratio	0.78
P/TBV Ratio	n/a
P/FCF Ratio	8.69
P/OCF Ratio	n/a
PEG Ratio	0.69

Financial Ratio History

Enterprise Valuation

EV / Earnings	1,245.73
EV / Sales	8.65
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	15.09

Financial Position

The company has a current ratio of 0.14, with a Debt / Equity ratio of 0.58.

Current Ratio	0.14
Quick Ratio	0.12
Debt / Equity	0.58
Debt / EBITDA	131.34
Debt / FCF	6.53
Interest Coverage	-0.12

Financial Efficiency

Return on equity (ROE) is 0.11% and return on invested capital (ROIC) is -0.07%.

Return on Equity (ROE)	0.11%
Return on Assets (ROA)	-0.04%
Return on Capital (ROIC)	-0.07%
Revenue Per Employee	89,294
Profits Per Employee	620
Employee Count	7,700
Asset Turnover	0.05
Inventory Turnover	76.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-12.28%
50-Day Moving Average	4.78
200-Day Moving Average	4.41
Relative Strength Index (RSI)	60.42
Average Volume (20 Days)	742,537

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ryman Healthcare had revenue of NZD 687.56 million and earned 4.78 million in profits. Earnings per share was 0.01.

Revenue	687.56M
Gross Profit	35.68M
Operating Income	-8.13M
Pretax Income	-144.93M
Net Income	4.78M
EBITDA	15.83M
EBIT	-8.13M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 52.14 million in cash and 2.57 billion in debt, giving a net cash position of -2.52 billion or -3.68 per share.

Cash & Cash Equivalents	52.14M
Total Debt	2.57B
Net Cash	-2.52B
Net Cash Per Share	-3.68
Equity (Book Value)	4.42B
Book Value Per Share	6.45
Working Capital	-5.13B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 658.48 million and capital expenditures -264.42 million, giving a free cash flow of 394.06 million.

Operating Cash Flow	658.48M
Capital Expenditures	-264.42M
Free Cash Flow	394.06M
FCF Per Share	0.58

Full Cash Flow Statement

Margins

Gross margin is 5.19%, with operating and profit margins of -1.18% and 0.69%.

Gross Margin	5.19%
Operating Margin	-1.18%
Pretax Margin	-21.08%
Profit Margin	0.69%
EBITDA Margin	2.30%
EBIT Margin	-1.18%
FCF Margin	57.31%

Dividends & Yields

Ryman Healthcare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.18%
Shareholder Yield	-33.18%
Earnings Yield	0.14%
FCF Yield	11.50%

Dividend Details

Stock Splits

The last stock split was on January 29, 2007. It was a forward split with a ratio of 5.

Last Split Date	Jan 29, 2007
Split Type	Forward
Split Ratio	5

Scores

Ryman Healthcare has an Altman Z-Score of 0.19. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.19
Piotroski F-Score	n/a